Tema Oncology ETF
ETFYour view on CANC
Tema Oncology ETF
ETFTemaSentiment
AUM (USD)
$193.73M
Expense Ratio
0.99%
Holdings
57
Sentiment
Overview for Tema Oncology ETF
- Fund Type
- ETF
- Fund Issuer
- Tema
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- August 14, 2023
- Domicile
- US
- Website
- temaetfs.com/canc
- Fund Type
- ETF
- Fund Issuer
- Tema
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- August 14, 2023
- Domicile
- US
- Website
- temaetfs.com/canc
- Fund Type
- ETF
- Fund Issuer
- Tema
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- August 14, 2023
- Domicile
- US
- Website
- temaetfs.com/canc
About this fund
The Tema Oncology ETF (CANC) seeks to invest in companies that potentially stand to benefit from further advances in oncology related biotechnology and healthcare.
CANC Stock Price
Key Facts
EquityExpense Ratio
0.99%
AUM
$193.73M
Fund Details
Expense Ratio
0.99%
Assets Under Management
$193.73M
NAV
$40.87 USD
Holdings
57
Average Volume
30.9K
Inception Date
August 14, 2023
Asset Class
Equity
Fund Issuer
Tema
Domicile
US
ISIN
US87975E7013
CUSIP
87975E701
NAV Currency
USD
Expense Ratio
0.99%
Assets Under Management
$193.73M
NAV
$40.87 USD
Holdings
57
Average Volume
30.9K
Inception Date
August 14, 2023
Asset Class
Equity
Fund Issuer
Tema
Domicile
US
ISIN
US87975E7013
CUSIP
87975E701
NAV Currency
USD
Latest headlines and company announcements for this company. Press releases and market coverage, newest first.
News
this company valued side by side against its closest peers. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.